FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2899973971> ?p ?o ?g. }

• W2899973971 endingPage "96" @default.
• W2899973971 startingPage "89" @default.
• W2899973971 abstract "Alpha1-Proteinase Inhibitor, Modified Process (Alpha-1 MP) is used for augmentation therapy in alpha1-antitrypsin deficiency (AATD), an extremely rare disease in Japan. Weekly doses of 60 mg/kg Alpha-1 MP have been shown to be safe and well tolerated in non-Japanese subjects, but the safety and pharmacokinetics (PK) have not been evaluated in Japanese subjects. The objectives of this study were to evaluate the safety and PK of 60 mg/kg Alpha-1 MP administered by weekly IV infusions over 8 weeks in Japanese subjects with AATD.This was a multicenter, open-label trial in Japanese adults aged ≥20 years with AATD. Samples for evaluation of serum alpha1-PI concentration and PK parameters were collected at 10 time points until the seventh day after the last dose at Week 8: immediately before dosing, immediately after dosing (time 0), and 0.25, 2, 4, 8, 24, 48, 120, and 168 hours after dosing.Four subjects were analyzed. The median tmax was 0.534 h. Mean ± SD values for t½, Cmax, and AUC0-7days were 150.4 ± 36.18 h, 174.2 ± 30.51 mg/dL, and 14,913.2 ± 1633.45 mg*h/dL, respectively. Mean trough concentration at week 8 was 55.4 ± 7.23 mg/dL. Alpha-1 MP therapy was safe, with no serious adverse events or deaths reported. Two treatment-emergent adverse events of fatigue in one subject were considered to be possibly related.The PK and safety of Alpha-1 MP in Japanese subjects with AATD were consistent with the Alpha-1 MP profile in non-Japanese subjects (ClinicalTrials.gov: NCT02870309; JAPIC CTI: JapicCTI-163160)." @default.
• W2899973971 created "2018-11-16" @default.
• W2899973971 creator A5013199621 @default.
• W2899973971 creator A5014367279 @default.
• W2899973971 creator A5025695892 @default.
• W2899973971 creator A5032205244 @default.
• W2899973971 creator A5049914126 @default.
• W2899973971 creator A5054043122 @default.
• W2899973971 creator A5068813933 @default.
• W2899973971 creator A5080980467 @default.
• W2899973971 creator A5081243390 @default.
• W2899973971 creator A5084914364 @default.
• W2899973971 creator A5089753955 @default.
• W2899973971 date "2019-01-01" @default.
• W2899973971 modified "2023-10-18" @default.
• W2899973971 title "Safety and pharmacokinetics of Alpha-1 MP (Prolastin®-C) in Japanese patients with alpha1-antitrypsin (AAT) deficiency" @default.
• W2899973971 cites W1608230281 @default.
• W2899973971 cites W1921725433 @default.
• W2899973971 cites W1988154867 @default.
• W2899973971 cites W1993347912 @default.
• W2899973971 cites W2027212845 @default.
• W2899973971 cites W2030201588 @default.
• W2899973971 cites W2064272773 @default.
• W2899973971 cites W2064411615 @default.
• W2899973971 cites W2093218391 @default.
• W2899973971 cites W2119128997 @default.
• W2899973971 cites W2125078269 @default.
• W2899973971 cites W2130915430 @default.
• W2899973971 cites W2167941825 @default.
• W2899973971 cites W2260903092 @default.
• W2899973971 cites W2323886210 @default.
• W2899973971 cites W2588299338 @default.
• W2899973971 cites W2601839973 @default.
• W2899973971 cites W2623610960 @default.
• W2899973971 cites W2764320461 @default.
• W2899973971 doi "https://doi.org/10.1016/j.resinv.2018.09.006" @default.
• W2899973971 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30416054" @default.
• W2899973971 hasPublicationYear "2019" @default.
• W2899973971 type Work @default.
• W2899973971 sameAs 2899973971 @default.
• W2899973971 citedByCount "5" @default.
• W2899973971 countsByYear W28999739712019 @default.
• W2899973971 countsByYear W28999739712020 @default.
• W2899973971 countsByYear W28999739712022 @default.
• W2899973971 crossrefType "journal-article" @default.
• W2899973971 hasAuthorship W2899973971A5013199621 @default.
• W2899973971 hasAuthorship W2899973971A5014367279 @default.
• W2899973971 hasAuthorship W2899973971A5025695892 @default.
• W2899973971 hasAuthorship W2899973971A5032205244 @default.
• W2899973971 hasAuthorship W2899973971A5049914126 @default.
• W2899973971 hasAuthorship W2899973971A5054043122 @default.
• W2899973971 hasAuthorship W2899973971A5068813933 @default.
• W2899973971 hasAuthorship W2899973971A5080980467 @default.
• W2899973971 hasAuthorship W2899973971A5081243390 @default.
• W2899973971 hasAuthorship W2899973971A5084914364 @default.
• W2899973971 hasAuthorship W2899973971A5089753955 @default.
• W2899973971 hasConcept C112705442 @default.
• W2899973971 hasConcept C126322002 @default.
• W2899973971 hasConcept C141071460 @default.
• W2899973971 hasConcept C197934379 @default.
• W2899973971 hasConcept C22979827 @default.
• W2899973971 hasConcept C2775944032 @default.
• W2899973971 hasConcept C2777288759 @default.
• W2899973971 hasConcept C2780535462 @default.
• W2899973971 hasConcept C49453240 @default.
• W2899973971 hasConcept C64943373 @default.
• W2899973971 hasConcept C71924100 @default.
• W2899973971 hasConcept C90924648 @default.
• W2899973971 hasConceptScore W2899973971C112705442 @default.
• W2899973971 hasConceptScore W2899973971C126322002 @default.
• W2899973971 hasConceptScore W2899973971C141071460 @default.
• W2899973971 hasConceptScore W2899973971C197934379 @default.
• W2899973971 hasConceptScore W2899973971C22979827 @default.
• W2899973971 hasConceptScore W2899973971C2775944032 @default.
• W2899973971 hasConceptScore W2899973971C2777288759 @default.
• W2899973971 hasConceptScore W2899973971C2780535462 @default.
• W2899973971 hasConceptScore W2899973971C49453240 @default.
• W2899973971 hasConceptScore W2899973971C64943373 @default.
• W2899973971 hasConceptScore W2899973971C71924100 @default.
• W2899973971 hasConceptScore W2899973971C90924648 @default.
• W2899973971 hasIssue "1" @default.
• W2899973971 hasLocation W28999739711 @default.
• W2899973971 hasLocation W28999739712 @default.
• W2899973971 hasOpenAccess W2899973971 @default.
• W2899973971 hasPrimaryLocation W28999739711 @default.
• W2899973971 hasRelatedWork W2002994412 @default.
• W2899973971 hasRelatedWork W2021076152 @default.
• W2899973971 hasRelatedWork W2051764329 @default.
• W2899973971 hasRelatedWork W2064759457 @default.
• W2899973971 hasRelatedWork W2323286668 @default.
• W2899973971 hasRelatedWork W2800682907 @default.
• W2899973971 hasRelatedWork W3042563287 @default.
• W2899973971 hasRelatedWork W3151787567 @default.
• W2899973971 hasRelatedWork W3185247380 @default.
• W2899973971 hasRelatedWork W3207313530 @default.
• W2899973971 hasVolume "57" @default.
• W2899973971 isParatext "false" @default.
• W2899973971 isRetracted "false" @default.

• next